DOCSLIB.ORG

Increased Expression of Fibronectin Leucine-Rich Transmembrane Protein 3 in The

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Increased Expression of Fibronectin Leucine-Rich Transmembrane Protein 3 in The Research Articles: Neurobiology of Disease Increased expression of fibronectin leucine- rich transmembrane protein 3 in the dorsal root ganglion induces neuropathic pain in rats https://doi.org/10.1523/JNEUROSCI.0295-19.2019 Cite as: J. Neurosci 2019; 10.1523/JNEUROSCI.0295-19.2019 Received: 4 February 2019 Revised: 17 May 2019 Accepted: 6 June 2019 This Early Release article has been peer-reviewed and accepted, but has not been through the composition and copyediting processes. The final version may differ slightly in style or formatting and will contain links to any extended data. Alerts: Sign up at www.jneurosci.org/alerts to receive customized email alerts when the fully formatted version of this article is published. Copyright © 2019 the authors 1 Increased expression of fibronectin leucine-rich transmembrane protein 3 in the 2 dorsal root ganglion induces neuropathic pain in rats 3 4 Moe Yamada1, Yuki Fujita2,3, Yasufumi Hayano2, Hideki Hayakawa4, Kousuke Baba4, 5 Hideki Mochizuki4, and Toshihide Yamashita1,2,3,5 6 7 1Department of Molecular Neuroscience, Osaka University, Graduate School of Frontier 8 Biosciences, Osaka University, 1-3 Yamadaoka, Suita, Osaka, 565-0871, Japan 9 2Department of Molecular Neuroscience, Osaka University Graduate School of 10 Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan 11 3Immunology Frontier Research Center, Osaka University, 3-1 Yamadaoka, Suita, 12 Osaka, 565-0871, Japan 13 4Department of Neurology, Graduate School of Medicine, Osaka University, 2-2 14 Yamadaoka, Suita, Osaka 565-0871, Japan 15 5Department of Neuro-Medical Science, Graduate School of Medicine, Osaka 16 University, Osaka, Japan 17 18 Abbreviated title: FLRT3 in neuropathic pain development 19 20 Corresponding author: Toshihide Yamashita 21 Department of Molecular Neuroscience, Graduate School of Medicine, Osaka 22 University, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan 23 Tel.: 81-6-68793661; Fax: 81-6-68793669 24 Email address: [email protected] 1 25 26 Number of pages: 40 27 Number of figures: 6 28 29 Number of words in the Abstract: 187 30 Number of words in the Introduction: 435 31 Number of words in the Discussion: 1408 32 2 33 Abstract 34 Neuropathic pain is a chronic condition that occurs frequently after nerve injury and 35 induces hypersensitivity or allodynia characterized by aberrant neuronal excitability in 36 the spinal cord dorsal horn. Fibronectin leucine-rich transmembrane protein 3 (FLRT3) 37 is a modulator of neurite outgrowth, axon pathfinding, and cell adhesion, which is 38 upregulated in the dorsal horn following peripheral nerve injury. However, the function 39 of FLRT3 in adults remains unknown. Therefore, we aimed to investigate the 40 involvement of spinal FLRT3 in neuropathic pain using rodent models. In the dorsal 41 horns of male rats, FLRT3 protein levels increased at day 4 after peripheral nerve injury. 42 In the dorsal root ganglion (DRG), FLRT3 was expressed in activating transcription 43 factor 3-positive, injured sensory neurons. Peripheral nerve injury stimulated Flrt3 44 transcription in the DRG, but not in the spinal cord. Intrathecal administration of FLRT3 45 protein to naïve rats induced mechanical allodynia and GluN2B phosphorylation in the 46 spinal cord. DRG-specific FLRT3 overexpression using adeno-associated virus also 47 produced mechanical allodynia. Conversely, a function-blocking FLRT3 antibody 48 attenuated mechanical allodynia after partial sciatic nerve ligation. Therefore, FLRT3 49 derived from injured DRG neurons increases dorsal horn excitability and induces 50 mechanical allodynia. 51 52 Significance Statement 53 Neuropathic pain occurs frequently after nerve injury and is associated with abnormal 54 neuronal excitability in the spinal cord. Fibronectin leucine-rich transmembrane protein 55 3 (FLRT3) regulates neurite outgrowth and cell adhesion. Here, nerve injury increased 56 FLRT3 protein levels in the spinal cord dorsal root, despite the fact that Flrt3 transcripts 3 57 were only induced in the dorsal root ganglion (DRG). FLRT3 protein injection into the 58 rat spinal cord induced mechanical hypersensitivity, as did virus-mediated FLRT3 59 overexpression in DRG. Conversely, FLRT3 inhibition with antibodies attenuated 60 mechanically induced pain after nerve damage. These findings suggest that FLRT3 is 61 produced by injured DRG neurons and increases neuronal excitability in the dorsal horn, 62 leading to pain sensitization. Neuropathic pain induction is a novel function of FLRT3. 63 4 64 Introduction 65 Neuropathic pain is a chronic condition that occurs after nerve damage or in various 66 diseases (Basbaum et al., 2009). Nerve damage can lead to hypersensitivity, such as 67 allodynia and hyperalgesia, which are often resistant to analgesics (Woolf and Salter, 68 2000; Kohno et al., 2005; Baron et al., 2010). Study investigators have proposed 69 divergent mechanisms leading to chronic pain through alterations in nociceptive 70 pathways in the peripheral nervous system and CNS (von Hehn et al., 2012). The spinal 71 cord dorsal horn is a key region implicated in neuropathic pain development (Todd, 72 2010). The dorsal horn is not only a major transit point, where primary afferents engage 73 projection neurons anatomically, but is also an important region for normal sensory 74 processing and pathological conditions, such as neuropathic pain (Todd, 2010). Sensory 75 information from the peripheral tissue is delivered to the dorsal horn via primary 76 afferent neurons, after which it is processed and transmitted to secondary neurons 77 connecting to the brain (Julius and Basbaum, 2001). It is generally thought that 78 maladaptive changes in neural circuits occur in the dorsal horn after peripheral nerve 79 injury (Kuner and Flor, 2016). However, the molecular and cellular mechanisms 80 underlying neuropathic pain development in the dorsal horn neural circuits are complex 81 and remain unclear, hindering the development of novel analgesic treatments. 82 Fibronectin leucine-rich transmembrane protein-3 (FLRT3) contains a 83 fibronectin type-III domain and 10 leucine-rich repeats (Lacy et al., 1999). FLRT3 is 84 expressed in the embryonic and adult nervous systems (Robinson et al., 2004). In the 85 developing brain, FLRT3 functions as an axon-guidance factor by binding to the Unc5B 86 receptor (Yamagishi et al., 2011; Seiradake et al., 2014). FLRT3 also regulates 87 excitatory synapse formation by interacting with latrophilin 3 (LPHN3) (O’Sullivan et 5 88 al., 2012). In the adult, FLRT3 expression was increased in the dorsal horn and injured 89 nerve tissue after peripheral nerve transection (Robinson et al., 2004; Tsuji et al., 2004). 90 Although ex vivo studies showed that FLRT3 promotes neurite outgrowth (Robinson et 91 al., 2004; Tsuji et al., 2004), the function of FLRT3 in the adult CNS has not been 92 characterized, and no reports have addressed the pathological function of FLRT3 in the 93 dorsal horn after nerve injury. 94 In this study, our aim was to investigate the role of FLRT3 in spinal 95 sensitization and chronic pain in the adult spinal cord. We examined FLRT3 expression 96 in the dorsal horns of adult rats after peripheral nerve injury, as well as the effects of 97 spinal FLRT3 on mechanical sensitivity using anti-FLRT3 antibody administration in a 98 chronic pain model. Our results indicate that FLRT3 is involved in neuronal plasticity in 99 the dorsal horn circuitry, leading to neuropathic pain. 100 101 Materials and Methods 102 Animals 103 All animal experiments were performed in accordance with the Osaka University 104 Medical School guide for animal care. All experimental protocols involving animals 105 were approved by the institutional committee of Osaka University. We purchased 6- to 106 10-week-old male Wistar/ST rats from Japan SLC, Inc. (Hamamatsu, Japan). The 107 animals were fed food and water ad libitum. 108 109 Models for neuropathic or inflammatory pain 110 To induce neuropathic pain, we performed partial sciatic nerve ligation (PSL) surgery 111 for peripheral-nerve injury and antibody-administration experiments, or spinal 6 112 nerve-ligation (SNL) surgery for the Flrt3-knockdown experiment, as previously 113 described (Seltzer et al., 1990). In brief, for the PSL model, we used 4-0 sutures 114 (Alfresa Pharma Co., Osaka, Japan) to tightly ligate the left sciatic nerve. For the SNL 115 model, we carefully exposed the left L4 dorsal spinal nerve and tightly ligated it with 116 4-0 silk sutures around the spinal root (2 points, 1 mm apart). All surgical procedures 117 were performed under 2% isoflurane (Pfizer Japan Inc., Tokyo, Japan) anesthesia. 118 Drugs to reduce post-operative pain were not administered. 119 120 Behavioral testing 121 In the neuropathic pain model, we measured the mechanical paw-withdrawal threshold 122 using the von Frey filament test, as previously described (Chaplan et al., 1994). Rats 123 were individually placed in a plastic cage on wire mesh and habituated for 5–10 min. A 124 calibrated von Frey filament (Semmes–Weinstein von Frey esthesiometer; Muromachi 125 Kikai Co., Tokyo, Japan) was applied to the plantar surface of the hind paw, and the 126 50% paw-withdrawal threshold was determined using the up–down method. Results are 127 presented either as raw data or the percentage of the baseline threshold on day 0 in each 128 rat. All behavioral analyses were performed under single-blind conditions. The rats that 129 showed motor deficits or that were non-responders to 15 g of von Frey filaments after 130 the injury were excluded from the quantitative analysis. The wide range of baseline von 131 Frey thresholds might be dependent on the difference in pain models, including PSL, 132 SNL, catheter infusion, and virus infection. 133 134 Catheter implantation 135 For recombinant protein or antibody administration, an intrathecal cannula was 7 136 implanted as previously described (Maeda et al., 2009). Briefly, a polyethylene catheter 137 (PE-10, Clay-Adams, Becton-Dickinson and Co.) attached to the osmotic minipump 138 (0.25 μL/h; Model 1002, Alzet, Palo Alto, CA, USA) was inserted between spinal cord 139 vertebrae L5 and L6 to contact the lumbar enlargement.
Load more

Recommended publications
  • Recombinant Human FLRT1 Catalog Number: 2794-FL
    Recombinant Human FLRT1 Catalog Number: 2794-FL DESCRIPTION Source Mouse myeloma cell line, NS0­derived human FLRT1 protein Ile21­Pro524, with a C­terminal 6­His tag Accession # Q9NZU1 N­terminal Sequence Ile21 Analysis Predicted Molecular 56.3 kDa Mass SPECIFICATIONS SDS­PAGE 70­80 kDa, reducing conditions Activity Measured by the ability of the immobilized protein to support the adhesion of Neuro­2A mouse neuroblastoma cells. Recombinant Human FLRT1 immobilized at 2.5 μg/mL, 100 μL/well, will meidate > 50% Neuro­2A cell adhesion. Optimal dilutions should be determined by each laboratory for each application. Endotoxin Level <0.10 EU per 1 μg of the protein by the LAL method. Purity >95%, by SDS­PAGE under reducing conditions and visualized by silver stain. Formulation Lyophilized from a 0.2 μm filtered solution in PBS. See Certificate of Analysis for details. PREPARATION AND STORAGE Reconstitution Reconstitute at 200 μg/mL in sterile PBS. Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. Stability & Storage Use a manual defrost freezer and avoid repeated freeze­thaw cycles. l 12 months from date of receipt, ­20 to ­70 °C as supplied. l 1 month, 2 to 8 °C under sterile conditions after reconstitution. l 3 months, ­20 to ­70 °C under sterile conditions after reconstitution. BACKGROUND FLRT1 is one of three FLRT (fibronectin, leucine rich repeat, transmembrane) glycoproteins expressed in distinct areas of the developing brain and other tissues (1, 2). The 90 kDa type I transmembrane (TM) human FLRT1 is synthesized as a 646 amino acid (aa) precursor with a 20 aa signal sequence, a 504 aa extracellular domain (ECD), a 21 aa TM segment and a 101 aa cytoplasmic region.
    [Show full text]
  • Increased Expression of Fibronectin Leucine-Rich Transmembrane Protein 3 in the Dorsal Root Ganglion Induces Neuropathic Pain in Rats
    The Journal of Neuroscience, September 18, 2019 • 39(38):7615–7627 • 7615 Neurobiology of Disease Increased Expression of Fibronectin Leucine-Rich Transmembrane Protein 3 in the Dorsal Root Ganglion Induces Neuropathic Pain in Rats Moe Yamada,1 Yuki Fujita,2,3 Yasufumi Hayano,2 Hideki Hayakawa,4 Kousuke Baba,4 Hideki Mochizuki,4 and X Toshihide Yamashita1,2,3,5 1Department of Molecular Neuroscience, Graduate School of Frontier Biosciences, 2Department of Molecular Neuroscience, Graduate School of Medicine, 3Immunology Frontier Research Center, 4Department of Neurology, Graduate School of Medicine, and 5Department of Neuro-Medical Science, Graduate School of Medicine, Osaka University, Osaka 565-0871, Japan Neuropathic pain is a chronic condition that occurs frequently after nerve injury and induces hypersensitivity or allodynia characterized by aberrant neuronal excitability in the spinal cord dorsal horn. Fibronectin leucine-rich transmembrane protein 3 (FLRT3) is a modu- lator of neurite outgrowth, axon pathfinding, and cell adhesion, which is upregulated in the dorsal horn following peripheral nerve injury. However, the function of FLRT3 in adults remains unknown. Therefore, we aimed to investigate the involvement of spinal FLRT3 in neuropathic pain using rodent models. In the dorsal horns of male rats, FLRT3 protein levels increased at day 4 after peripheral nerve injury. In the DRG, FLRT3 was expressed in activating transcription factor 3-positive, injured sensory neurons. Peripheral nerve injury stimulated Flrt3 transcription in the DRG but not in the spinal cord. Intrathecal administration of FLRT3 protein to naive rats induced mechanical allodynia and GluN2B phosphorylation in the spinal cord. DRG-specific FLRT3 overexpression using adeno-associated virus also produced mechanical allodynia.
    [Show full text]
  • Genetic Ablation of FLRT3 Reveals a Novel Morphogenetic Function for the Anterior Visceral Endoderm in Suppressing Mesoderm Differentiation
    Downloaded from genesdev.cshlp.org on March 12, 2020 - Published by Cold Spring Harbor Laboratory Press Genetic ablation of FLRT3 reveals a novel morphogenetic function for the anterior visceral endoderm in suppressing mesoderm differentiation Joaquim Egea,1,5,8 Christian Erlacher,1,5 Eloi Montanez,2 Ingo Burtscher,3 Satoru Yamagishi,1 Martin Heß,4 Falko Hampel,1 Rodrigo Sanchez,1,6 Maria Teresa Rodriguez-Manzaneque,2 Michael R. Bösl,1 Reinhard Fässler,2 Heiko Lickert,3 and Rüdiger Klein1,7 1Department of Molecular Neurobiology, Max-Planck Institute of Neurobiology, 82152 Martinsried, Germany; 2Department of Molecular Medicine, Max-Planck Institute for Biochemistry, 82152 Martinsried, Germany; 3Institute of Stem Cell Research, Helmholtz Zentrum München, 85764 Neuherberg, Germany; 4Biozentrum der LMU Biology, 82152 Martinsried, Germany During early mouse development, the anterior visceral endoderm (AVE) secretes inhibitor and activator signals that are essential for establishing the anterior–posterior (AP) axis of the embryo and for restricting mesoderm formation to the posterior epiblast in the primitive streak (PS) region. Here we show that AVE cells have an additional morphogenetic function. These cells express the transmembrane protein FLRT3. Genetic ablation of FLRT3 did not affect the signaling functions of the AVE according to the normal expression pattern of Nodal and Wnt and the establishment of a proper AP patterning in the epiblast. However, FLRT3−/− embryos showed a highly disorganized basement membrane (BM) in the AVE region. Subsequently, adjacent anterior epiblast cells displayed an epithelial-to-mesenchymal transition (EMT)-like process characterized by the loss of cell polarity, cell ingression, and the up-regulation of the EMT and the mesodermal marker genes Eomes, Brachyury/T, and FGF8.
    [Show full text]
  • The C20orf133 Gene Is Disrupted in a Patient with Kabuki Syndrome
    562 ORIGINAL ARTICLE J Med Genet: first published as 10.1136/jmg.2007.049510 on 23 June 2007. Downloaded from The C20orf133 gene is disrupted in a patient with Kabuki syndrome Nicole M C Maas, Tom Van de Putte, Cindy Melotte, Annick Francis, Constance T R M Schrander-Stumpel, Damien Sanlaville, This paper is freely available online David Genevieve, Stanislas Lyonnet, Boyan Dimitrov, under the BMJ Journals unlocked scheme, Koenraad Devriendt, Jean-Pierre Fryns, Joris R Vermeesch see http://jmg.bmj.com/info/unlocked.dtl ................................................................................................................................... J Med Genet 2007;44:562–569. doi: 10.1136/jmg.2007.049510 See end of article for authors’ affiliations Background: Kabuki syndrome (KS) is a rare, clinically recognisable, congenital mental retardation ........................ syndrome. The aetiology of KS remains unknown. Correspondence to: Methods: Four carefully selected patients with KS were screened for chromosomal imbalances using array J R Vermeesch, Center for comparative genomic hybridisation at 1 Mb resolution. Human Genetics, Herestraat Results: In one patient, a 250 kb de novo microdeletion at 20p12.1 was detected, deleting exon 5 of 49, 3000 Leuven, Belgium; C20orf133. The function of this gene is unknown. In situ hybridisation with the mouse orthologue of joris.vermeesch@med. kuleuven.be C20orf133 showed expression mainly in brain, but also in kidney, eye, inner ear, ganglia of the peripheral nervous system and lung. Received 1 February 2007 Conclusion: The de novo nature of the deletion, the expression data and the fact that C20orf133 carries a Revised 15 May 2007 macro domain, suggesting a role for the gene in chromatin biology, make the gene a likely candidate to Accepted 22 May 2007 Published Online First cause the phenotype in this patient with KS.
    [Show full text]
  • Short-Term Western-Style Diet Negatively Impacts Reproductive Outcomes in Primates
    Short-term Western-style diet negatively impacts reproductive outcomes in primates Sweta Ravisankar, … , Shawn L. Chavez, Jon D. Hennebold JCI Insight. 2021;6(4):e138312. https://doi.org/10.1172/jci.insight.138312. Research Article Metabolism Reproductive biology A maternal Western-style diet (WSD) is associated with poor reproductive outcomes, but whether this is from the diet itself or underlying metabolic dysfunction is unknown. Here, we performed a longitudinal study using regularly cycling female rhesus macaques (n = 10) that underwent 2 consecutive in vitro fertilization (IVF) cycles, one while consuming a low-fat diet and another 6–8 months after consuming a high-fat WSD. Metabolic data were collected from the females prior to each IVF cycle. Follicular fluid (FF) and oocytes were assessed for cytokine/steroid levels and IVF potential, respectively. Although transition to a WSD led to weight gain and increased body fat, no difference in insulin levels was observed. A significant decrease in IL-1RA concentration and the ratio of cortisol/cortisone was detected in FF after WSD intake. Despite an increased probability of isolating mature oocytes, a 44% reduction in blastocyst number was observed with WSD consumption, and time-lapse imaging revealed delayed mitotic timing and multipolar divisions. RNA sequencing of blastocysts demonstrated dysregulation of genes involved in RNA binding, protein channel activity, mitochondrial function and pluripotency versus cell differentiation after WSD consumption. Thus, short-term WSD consumption promotes a proinflammatory intrafollicular microenvironment that is associated with impaired preimplantation development in the absence of large-scale metabolic changes. Find the latest version: https://jci.me/138312/pdf RESEARCH ARTICLE Short-term Western-style diet negatively impacts reproductive outcomes in primates Sweta Ravisankar,1,2 Alison Y.
    [Show full text]
  • A Shared Genetic Basis for Self- Limited Delayed Puberty and Idiopathic Hypogonadotropic Hypogonadism
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Harvard University - DASH A Shared Genetic Basis for Self- Limited Delayed Puberty and Idiopathic Hypogonadotropic Hypogonadism The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters Citation Zhu, Jia. 2015. A Shared Genetic Basis for Self-Limited Delayed Puberty and Idiopathic Hypogonadotropic Hypogonadism. Doctoral dissertation, Harvard Medical School. Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:15821591 Terms of Use This article was downloaded from Harvard University’s DASH repository, and is made available under the terms and conditions applicable to Other Posted Material, as set forth at http:// nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of- use#LAA TABLE OF CONTENTS: ABSTRACT ................................................................................................................................... 4 GLOSSARY OF ABBREVIATIONS AND GENE NAMES .................................................... 6 1 INTRODUCTION ...................................................................................................................... 9 1.1 Function of the hypothalamic-pituitary-gonadal (HPG) axis in puberty ...................... 9 1.2 Regulation of the HPG axis ........................................................................................ 10 1.3 Origin of the GnRH neuronal network ......................................................................
    [Show full text]
  • Identification of Key Genes and Pathways in Pancreatic Cancer
    G C A T T A C G G C A T genes Article Identification of Key Genes and Pathways in Pancreatic Cancer Gene Expression Profile by Integrative Analysis Wenzong Lu * , Ning Li and Fuyuan Liao Department of Biomedical Engineering, College of Electronic and Information Engineering, Xi’an Technological University, Xi’an 710021, China * Correspondence: [email protected]; Tel.: +86-29-86173358 Received: 6 July 2019; Accepted: 7 August 2019; Published: 13 August 2019 Abstract: Background: Pancreatic cancer is one of the malignant tumors that threaten human health. Methods: The gene expression profiles of GSE15471, GSE19650, GSE32676 and GSE71989 were downloaded from the gene expression omnibus database including pancreatic cancer and normal samples. The differentially expressed genes between the two types of samples were identified with the Limma package using R language. The gene ontology functional and pathway enrichment analyses of differentially-expressed genes were performed by the DAVID software followed by the construction of a protein–protein interaction network. Hub gene identification was performed by the plug-in cytoHubba in cytoscape software, and the reliability and survival analysis of hub genes was carried out in The Cancer Genome Atlas gene expression data. Results: The 138 differentially expressed genes were significantly enriched in biological processes including cell migration, cell adhesion and several pathways, mainly associated with extracellular matrix-receptor interaction and focal adhesion pathway in pancreatic cancer. The top hub genes, namely thrombospondin 1, DNA topoisomerase II alpha, syndecan 1, maternal embryonic leucine zipper kinase and proto-oncogene receptor tyrosine kinase Met were identified from the protein–protein interaction network.
    [Show full text]
  • Quantitative Proteomics Reveals Significant Differences
    cells Article Quantitative Proteomics Reveals Significant Differences between Mouse Brain Formations in Expression of Proteins Involved in Neuronal Plasticity during Aging Dominika Drulis-Fajdasz 1,† , Kinga Gostomska-Pampuch 2,3,† , Przemysław Duda 1 , Jacek Roman Wi´sniewski 2 and Dariusz Rakus 1,* 1 Department of Molecular Physiology and Neurobiology, University of Wrocław, Sienkiewicza 21, 50-335 Wrocław, Poland; [email protected] (D.D.-F.); [email protected] (P.D.) 2 Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, 82152 Martinsried, Germany; [email protected] (K.G.-P.); [email protected] (J.R.W.) 3 Department of Biochemistry and Immunochemistry, Wrocław Medical University, Chałubi´nskiego10, 50-368 Wrocław, Poland * Correspondence: [email protected] † The authors participated equally. Abstract: Aging is associated with a general decline in cognitive functions, which appears to be due to alterations in the amounts of proteins involved in the regulation of synaptic plasticity. Here, we present a quantitative analysis of proteins involved in neurotransmission in three brain regions, namely, the hippocampus, the cerebral cortex and the cerebellum, in mice aged 1 and 22 months, Citation: Drulis-Fajdasz, D.; using the total protein approach technique. We demonstrate that although the titer of some proteins Gostomska-Pampuch, K.; Duda, P.; involved in neurotransmission and synaptic plasticity is affected by aging in a similar manner Wi´sniewski,J.R.; Rakus, D. Quantitative Proteomics Reveals in all the studied brain formations, in fact, each of the formations represents its own mode of Significant Differences between aging.
    [Show full text]
  • The DNA Sequence and Comparative Analysis of Human Chromosome 20
    articles The DNA sequence and comparative analysis of human chromosome 20 P. Deloukas, L. H. Matthews, J. Ashurst, J. Burton, J. G. R. Gilbert, M. Jones, G. Stavrides, J. P. Almeida, A. K. Babbage, C. L. Bagguley, J. Bailey, K. F. Barlow, K. N. Bates, L. M. Beard, D. M. Beare, O. P. Beasley, C. P. Bird, S. E. Blakey, A. M. Bridgeman, A. J. Brown, D. Buck, W. Burrill, A. P. Butler, C. Carder, N. P. Carter, J. C. Chapman, M. Clamp, G. Clark, L. N. Clark, S. Y. Clark, C. M. Clee, S. Clegg, V. E. Cobley, R. E. Collier, R. Connor, N. R. Corby, A. Coulson, G. J. Coville, R. Deadman, P. Dhami, M. Dunn, A. G. Ellington, J. A. Frankland, A. Fraser, L. French, P. Garner, D. V. Grafham, C. Grif®ths, M. N. D. Grif®ths, R. Gwilliam, R. E. Hall, S. Hammond, J. L. Harley, P. D. Heath, S. Ho, J. L. Holden, P. J. Howden, E. Huckle, A. R. Hunt, S. E. Hunt, K. Jekosch, C. M. Johnson, D. Johnson, M. P. Kay, A. M. Kimberley, A. King, A. Knights, G. K. Laird, S. Lawlor, M. H. Lehvaslaiho, M. Leversha, C. Lloyd, D. M. Lloyd, J. D. Lovell, V. L. Marsh, S. L. Martin, L. J. McConnachie, K. McLay, A. A. McMurray, S. Milne, D. Mistry, M. J. F. Moore, J. C. Mullikin, T. Nickerson, K. Oliver, A. Parker, R. Patel, T. A. V. Pearce, A. I. Peck, B. J. C. T. Phillimore, S. R. Prathalingam, R. W. Plumb, H. Ramsay, C. M.
    [Show full text]
  • Human Leucine-Rich Repeat Proteins: a Genome-Wide Bioinformatic Categorization and Functional Analysis in Innate Immunity
    Human leucine-rich repeat proteins: a genome-wide bioinformatic categorization and functional analysis in innate immunity Aylwin C. Y. Nga,b,1, Jason M. Eisenberga,b,1, Robert J. W. Heatha, Alan Huetta, Cory M. Robinsonc, Gerard J. Nauc, and Ramnik J. Xaviera,b,2 aCenter for Computational and Integrative Biology, and Gastrointestinal Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; bThe Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142; and cMicrobiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261 Edited by Jeffrey I. Gordon, Washington University School of Medicine, St. Louis, MO, and approved June 11, 2010 (received for review February 17, 2010) In innate immune sensing, the detection of pathogen-associated proteins have been implicated in human diseases to date, notably molecular patterns by recognition receptors typically involve polymorphisms in NOD2 in Crohn disease (8, 9), CIITA in leucine-rich repeats (LRRs). We provide a categorization of 375 rheumatoid arthritis and multiple sclerosis (10), and TLR5 in human LRR-containing proteins, almost half of which lack other Legionnaire disease (11). identifiable functional domains. We clustered human LRR proteins Most LRR domains consist of a chain of between 2 and 45 by first assigning LRRs to LRR classes and then grouping the proteins LRRs (12). Each repeat in turn is typically 20 to 30 residues long based on these class assignments, revealing several of the resulting and can be divided into a highly conserved segment (HCS) fol- protein groups containing a large number of proteins with certain lowed by a variable segment (VS).
    [Show full text]
  • Genetic Ablation of FLRT3 Reveals a Novel Morphogenetic Function for the Anterior Visceral Endoderm in Suppressing Mesoderm Differentiation
    Downloaded from genesdev.cshlp.org on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Genetic ablation of FLRT3 reveals a novel morphogenetic function for the anterior visceral endoderm in suppressing mesoderm differentiation Joaquim Egea,1,5,8 Christian Erlacher,1,5 Eloi Montanez,2 Ingo Burtscher,3 Satoru Yamagishi,1 Martin Heß,4 Falko Hampel,1 Rodrigo Sanchez,1,6 Maria Teresa Rodriguez-Manzaneque,2 Michael R. Bösl,1 Reinhard Fässler,2 Heiko Lickert,3 and Rüdiger Klein1,7 1Department of Molecular Neurobiology, Max-Planck Institute of Neurobiology, 82152 Martinsried, Germany; 2Department of Molecular Medicine, Max-Planck Institute for Biochemistry, 82152 Martinsried, Germany; 3Institute of Stem Cell Research, Helmholtz Zentrum München, 85764 Neuherberg, Germany; 4Biozentrum der LMU Biology, 82152 Martinsried, Germany During early mouse development, the anterior visceral endoderm (AVE) secretes inhibitor and activator signals that are essential for establishing the anterior–posterior (AP) axis of the embryo and for restricting mesoderm formation to the posterior epiblast in the primitive streak (PS) region. Here we show that AVE cells have an additional morphogenetic function. These cells express the transmembrane protein FLRT3. Genetic ablation of FLRT3 did not affect the signaling functions of the AVE according to the normal expression pattern of Nodal and Wnt and the establishment of a proper AP patterning in the epiblast. However, FLRT3−/− embryos showed a highly disorganized basement membrane (BM) in the AVE region. Subsequently, adjacent anterior epiblast cells displayed an epithelial-to-mesenchymal transition (EMT)-like process characterized by the loss of cell polarity, cell ingression, and the up-regulation of the EMT and the mesodermal marker genes Eomes, Brachyury/T, and FGF8.
    [Show full text]
  • Genetic Analysis of FLRT Protein Family During Early Mouse Embryonic Development
    Genetic analysis of the FLRT family of proteins during early mouse embryonic development Dissertation Der Fakultät für Biologie der Ludwig-Maximilians-Universität München Eingereicht am 17. Februar 2009 von Christian Erlacher 1. Gutachter: Prof. Dr. Rüdiger Klein 2. Gutachter: PD Dr. Angelika Böttger Tag der mündlichen Prüfung: 24.04.2009 Work presented in this dissertation was performed in the laboratory of Prof. Dr. Rüdiger Klein, Department of Molecular Neurobiology, Max Planck Institute of Neurobiology, Martinsried, Germany. Work was performed under the supervision of Prof. Dr. Rüdiger Klein and Dr. Joaquim E g e a Ehrenwörtliche Versicherung Ich versichere hiermit ehrenwörtlich, dass die vorgelegte Dissertation von mir selbständig und ohne unerlaubte Beihilfe angefertigt ist. München, den (Unterschrift) Erklärung Hiermit erkläre ich, dass ich mich anderweitig einer Doktorprüfung ohne Erfolg nicht unterzogen habe. München, den (Unterschrift) Publication from the work presented in this dissertation # Joaquim E g e a* , Christian Erlacher*, Eloi Montanez, Ingo Burtscher, Satoru Yamagishi, Martin Heß, Falko Hampel, Rodrigo Sanchez, Maria Teresa Rodriguez-Manzaneque, Michael R. Bösl, Reinhard Fässler, Heiko Lickert, and Rüdiger Klein# „Genetic ablation of FLRT3 reveals a novel morphogenetic function for the anterior visceral endoderm in suppressing mesoderm differentiation.“ Genes & Development 22, Nr. 23 (Dec 2008): 3349-3362. * and #: These authors contributed equally to this work. Für Margareta und Hans Table of contents Abbreviations V List of Figures IX 1. Introduction 1 1.1. Preimplantation development 3 1.2. Postimplantation development 4 1.3. Axis specification 8 1.4. Molecular basis of axis formation 11 1.5. Gastrulation 15 1.6. Molecular mechanisms guiding gastrulation 18 1.7.
    [Show full text]